Moll MN, Nawaz Q, Kunisch E, Ahrens T, Walker T, Renkawitz T, Boccaccini AR, Westhauser F (2025)
Publication Type: Journal article
Publication year: 2025
Article Number: 02611929251366421
DOI: 10.1177/02611929251366421
Angiogenesis is an essential part of bone regeneration, as neovascularisation supports the supply of necessary oxygen, nutrients, and cellular transport. Bioactive glasses (BGs) have shown promise in enhancing both angiogenesis and bone regeneration. For the evaluation of the angiogenic potential of BGs, the chorioallantoic membrane (CAM) assay constitutes an attractive experimental model and has already gained increasing attention in BG-focused research. However, there is conflicting evidence as to whether the addition of cells, such as bone-marrow-derived mesenchymal stromal cells (BMSCs) to the CAM is necessary to facilitate the evaluation of the angiogenic potency of BGs. Therefore, in this study, the angiogenic potential of mesoporous bioactive glass nanoparticles (MBGNs; molar composition = 70% silica (SiO
APA:
Moll, M.N., Nawaz, Q., Kunisch, E., Ahrens, T., Walker, T., Renkawitz, T.,... Westhauser, F. (2025). Mesoporous bioactive glass nanoparticles exhibit intrinsic angiogenic potential in the chorioallantoic membrane assay, without the addition of exogenous cells. Atla-Alternatives To Laboratory Animals. https://doi.org/10.1177/02611929251366421
MLA:
Moll, Maximilian N., et al. "Mesoporous bioactive glass nanoparticles exhibit intrinsic angiogenic potential in the chorioallantoic membrane assay, without the addition of exogenous cells." Atla-Alternatives To Laboratory Animals (2025).
BibTeX: Download